Others have demonstrated that SARS-CoV-2 uses TGFβ to dampen the immune response, allowing viral persistence [29], and an increase in blood TGFβ during severe COVID-19 may be associated with disseminated intravascular coagulation (contained in alpha granules of platelets) [30]. Here, TGFB1 is linked to COVID-19.